Loading viewer...
investor_presentation
Format: PDF investor_presentation
A detailed investment analysis challenging Corsa Coal's valuation following the 2016 met coal price surge. The presentation argues that metallurgical coal demand faces structural headwinds from China's economic transition and the rising adoption of electric arc furnace mills that bypass met coal entirely. It derives a price target of $2.09, representing a 36% discount to the February 2016 trading price.
presentation
Karyopharm Therapeutics Investor Presentation — February 2020
investor_presentation
40 Pages
Karyopharm Therapeutics Inc.
Hyloris Pharmaceuticals 2023 Investor Presentation
investor_presentationinvestor_presentation
25 Pages
Hyloris Pharmaceuticals SA